1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. NAYA BIOSCIENCES

NAYA Biosciences

XNAS: NAYA

Download real time

2.31 -0.15 (-6.10%)

New 52W Low in past week

132.1K XNAS Volume

High volume+loss today

XNAS 19 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
5S
11W
0O
4T
1.4

Market Cap

Low in industry
-0.2

PE TTM

Negative PE TTM
0

PEG TTM

-0.2

Price to Book

Negative Price to Book
-0.6

Beta 1Year

Very Low volatility


Insider Trading disclosures for NAYA Biosciences

The latest disclosure was made by Barbara Ryan in NAYA Biosciences where a trade of 85,000 Stock Option (right to buy) done was reported to US exchanges on May 18, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Barbara Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 85,000 85,000 - - Stock Option (right to buy)
Michael J. Campbell Director, Chief Operating Officer 18 May 2023 83,000 83,000 - - Stock Option (right to buy)
Rebecca Messina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 85,000 85,000 - - Stock Option (right to buy)
Steven M. Shum Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 100,000 100,000 - - Stock Option (right to buy)
Trent D. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 85,000 85,000 - - Stock Option (right to buy)
Andrea Goren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 81,000 81,000 - - Stock option (right to buy)
Matthew K. Szot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 85,000 85,000 - - Stock Option (right to buy)
Rebecca Messina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 8,311 13,177 - 0 Common Stock
Steven M. Shum Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 57,018 57,018 - - Stock Option
Rebecca Messina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 10,098 10,098 - - Stock Option
Kevin Doody Director, Medical Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 7,480 177,306 - 0 Common Stock
Kevin Doody Director, Medical Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 9,088 9,088 - - Stock Option
Michael J. Campbell Director, Chief Operating Officer 15 Jan 2022 15,236 65,236 - 0 Common Stock
Michael J. Campbell Director, Chief Operating Officer 15 Jan 2022 18,513 18,513 - - Stock Option
Jeffrey Segal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 8,034 18,009 - 0 Common Stock
Jeffrey Segal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 9,762 9,762 - - Stock Option
Barbara Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 8,588 21,053 - 0 Common Stock
Barbara Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 10,435 10,435 - - Stock Option
Steven M. Shum Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 20,111 82,035 - 0 Common Stock
Trent D. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 8,865 22,438 - 0 Common Stock
Trent D. Davis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 10,771 10,771 - - Stock Option
Andrea Goren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 5,361 17,861 - 0 Common Stock
Andrea Goren Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 15,197 15,197 - - Stock Option
Matthew K. Szot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 12,454 12,454 - - Stock Option
Matthew K. Szot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2022 10,250 24,701 - 0 Common Stock
Andrea Goren Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.26 per share. 05 Oct 2021 30,674 76,383 - 3.3 99,997 Common Stock
Steven M. Shum Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 3.26 per share. 05 Oct 2021 30,674 61,924 - 3.3 99,997 Common Stock
Rebecca Messina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 6,239 6,239 - - Stock Option
Rebecca Messina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 May 2021 4,806 4,806 - 0 Common Stock
Matthew K. Szot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Nov 2020 2,339 2,339 - 0 Common Stock
Barbara Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Nov 2020 2,317 2,317 - - Stock Option
Barbara Ryan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Nov 2020 2,317 2,317 - 0 Common Stock
Jeffrey Segal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Nov 2020 1,137 1,137 - - Stock Option
Jeffrey Segal Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Nov 2020 1,137 1,137 - 0 Common Stock
Matthew K. Szot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Nov 2020 2,339 2,339 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters